Vaxxinity Stock Performance

VAXX Stock  USD 0.46  0.04  9.52%   
The entity has a beta of 1.46, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Vaxxinity will likely underperform. Vaxxinity has an expected return of -0.54%. Please make sure to validate Vaxxinity treynor ratio, as well as the relationship between the accumulation distribution and price action indicator , to decide if Vaxxinity performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaxxinity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1
Vaxxinity Wants to Bring Accessible Vaccines for Chronic Illness to Market - Cheddar
01/26/2024
2
Vaxxinity Shares Down 2.2 percent - MarketBeat
02/07/2024
3
Vaxxinity to Present Clinical and Preclinical Pipeline Data at ADPD 2024
02/13/2024
4
Vaxxinitys Cholesterol Vaccine Candidate Successfully Lowers LDL-C Preclinical Data Published
02/15/2024
5
Vaxxinity reports breakthrough in Parkinsons treatment
03/07/2024
6
Vaxxinity Shares Down 4.5 percent - MarketBeat
03/19/2024
7
Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
03/28/2024
8
Acquisition by Hornig George R of 129187 shares of Vaxxinity subject to Rule 16b-3
04/12/2024
Begin Period Cash Flow34.6 M
  

Vaxxinity Relative Risk vs. Return Landscape

If you would invest  71.00  in Vaxxinity on January 20, 2024 and sell it today you would lose (25.00) from holding Vaxxinity or give up 35.21% of portfolio value over 90 days. Vaxxinity is currently does not generate positive expected returns and assumes 5.3246% risk (volatility on return distribution) over the 90 days horizon. In different words, 47% of stocks are less volatile than Vaxxinity, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Vaxxinity is expected to under-perform the market. In addition to that, the company is 8.57 times more volatile than its market benchmark. It trades about -0.1 of its total potential returns per unit of risk. The NYSE Composite is currently generating roughly 0.1 per unit of volatility.

Vaxxinity Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Vaxxinity's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Vaxxinity, and traders can use it to determine the average amount a Vaxxinity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.1022

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsVAXX

Estimated Market Risk

 5.32
  actual daily
47
53% of assets are more volatile

Expected Return

 -0.54
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.1
  actual daily
0
Most of other assets perform better
Based on monthly moving average Vaxxinity is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Vaxxinity by adding Vaxxinity to a well-diversified portfolio.

Vaxxinity Fundamentals Growth

Vaxxinity Stock prices reflect investors' perceptions of the future prospects and financial health of Vaxxinity, and Vaxxinity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Vaxxinity Stock performance.

About Vaxxinity Performance

To evaluate Vaxxinity Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Vaxxinity generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Vaxxinity Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Vaxxinity market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Vaxxinity's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Days Of Inventory On Hand1.5 K1.5 K
Return On Tangible Assets(1.28)(1.35)
Return On Capital Employed(2.18)(2.29)
Return On Assets(1.28)(1.35)
Return On Equity(4.25)(4.03)

Things to note about Vaxxinity performance evaluation

Checking the ongoing alerts about Vaxxinity for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Vaxxinity help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Vaxxinity generated a negative expected return over the last 90 days
Vaxxinity has high historical volatility and very poor performance
Vaxxinity has some characteristics of a very speculative penny stock
Vaxxinity has a very high chance of going through financial distress in the upcoming years
Net Loss for the year was (56.93 M) with loss before overhead, payroll, taxes, and interest of (1.87 M).
Vaxxinity currently holds about 128.23 M in cash with (57.24 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.02, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Vaxxinity has a frail financial position based on the latest SEC disclosures
Roughly 51.0% of the company outstanding shares are owned by insiders
Latest headline from benzinga.com: Vaxxinity to Present Clinical Data at the Annual Academy of Neurology 2024 Annual Meeting
Evaluating Vaxxinity's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Vaxxinity's stock performance include:
  • Analyzing Vaxxinity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Vaxxinity's stock is overvalued or undervalued compared to its peers.
  • Examining Vaxxinity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Vaxxinity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Vaxxinity's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Vaxxinity's stock. These opinions can provide insight into Vaxxinity's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Vaxxinity's stock performance is not an exact science, and many factors can impact Vaxxinity's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Vaxxinity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Vaxxinity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaxxinity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Vaxxinity Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vaxxinity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
For more information on how to buy Vaxxinity Stock please use our How to Invest in Vaxxinity guide.
You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Complementary Tools for Vaxxinity Stock analysis

When running Vaxxinity's price analysis, check to measure Vaxxinity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxxinity is operating at the current time. Most of Vaxxinity's value examination focuses on studying past and present price action to predict the probability of Vaxxinity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxxinity's price. Additionally, you may evaluate how the addition of Vaxxinity to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Transaction History
View history of all your transactions and understand their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Is Vaxxinity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaxxinity. If investors know Vaxxinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaxxinity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.45)
Quarterly Revenue Growth
(0.57)
Return On Assets
(0.48)
Return On Equity
(1.51)
The market value of Vaxxinity is measured differently than its book value, which is the value of Vaxxinity that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxxinity's value that differs from its market value or its book value, called intrinsic value, which is Vaxxinity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxxinity's market value can be influenced by many factors that don't directly affect Vaxxinity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxxinity's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxxinity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxxinity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.